Towards the Clinical Use of Tolerogenic Dendritic Cells in Multiple Sclerosis by Applying the Immunomodulatory Effects of 1,25-dihydroxyvitamin D3 on Dendritic Cells to Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens | Publicación